BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9741938)

  • 1. Targeted delivery of plasmid DNA complexed with galactosylated poly(L-lysine).
    Hashida M; Takemura S; Nishikawa M; Takakura Y
    J Control Release; 1998 Apr; 53(1-3):301-10. PubMed ID: 9741938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted delivery of plasmid DNA to hepatocytes in vivo: optimization of the pharmacokinetics of plasmid DNA/galactosylated poly(L-lysine) complexes by controlling their physicochemical properties.
    Nishikawa M; Takemura S; Takakura Y; Hashida M
    J Pharmacol Exp Ther; 1998 Oct; 287(1):408-15. PubMed ID: 9765363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and in vivo gene transfer of plasmid DNA complexed with mannosylated poly(L-lysine) in mice.
    Nishikawa M; Takemura S; Yamashita F; Takakura Y; Meijer DK; Hashida M; Swart PJ
    J Drug Target; 2000; 8(1):29-38. PubMed ID: 10761643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical and disposition characteristics of antisense oligonucleotides complexed with glycosylated poly(L-lysine).
    Mahato RI; Takemura S; Akamatsu K; Nishikawa M; Takakura Y; Hashida M
    Biochem Pharmacol; 1997 Mar; 53(6):887-95. PubMed ID: 9113108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicochemical and pharmacokinetic characteristics of plasmid DNA/cationic liposome complexes.
    Mahato RI; Kawabata K; Nomura T; Takakura Y; Hashida M
    J Pharm Sci; 1995 Nov; 84(11):1267-71. PubMed ID: 8587040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor-mediated gene transfer to cells of hepatic origin by galactosylated albumin-polylysine complexes.
    Han J; Lim M; Yeom YI
    Biol Pharm Bull; 1999 Aug; 22(8):836-40. PubMed ID: 10480322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition characteristics of plasmid DNA in the single-pass rat liver perfusion system.
    Yoshida M; Mahato RI; Kawabata K; Takakura Y; Hashida M
    Pharm Res; 1996 Apr; 13(4):599-603. PubMed ID: 8710753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study on galactose-poly(ethylene glycol)-poly(L-lysine) as novel gene vector for targeting hepatocytes in vitro.
    Hu HM; Zhang X; Zhong NQ; Pan SR
    J Biomater Sci Polym Ed; 2012; 23(5):677-95. PubMed ID: 21375808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor-mediated transfer of DNA--galactosylated poly-L-lysine complexes into mammalian cells in vitro and in vivo.
    Dizhe EB; Akifiev BN; Missul BV; Orlov SV; Kidgotko OV; Sukonina VE; Denisenko AD; Perevozchikov AP
    Biochemistry (Mosc); 2001 Jan; 66(1):55-61. PubMed ID: 11240393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-mediated gene delivery and expression in vivo.
    Wu GY; Wu CH
    J Biol Chem; 1988 Oct; 263(29):14621-4. PubMed ID: 3049582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a targeted gene carrier, lactose-polyethylene glycol-grafted poly-L-lysine and its complex with plasmid DNA.
    Choi YH; Liu F; Choi JS; Kim SW; Park JS
    Hum Gene Ther; 1999 Nov; 10(16):2657-65. PubMed ID: 10566893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition characteristics of glycosylated poly(amino acids) as liver cell-specific drug carrier.
    Akamatsu K; Imai M; Yamasaki Y; Nishikawa M; Takakura Y; Hashida M
    J Drug Target; 1998; 6(3):229-39. PubMed ID: 9888309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palmitic acid-modified poly-L-lysine for non-viral delivery of plasmid DNA to skin fibroblasts.
    Abbasi M; Uludag H; Incani V; Olson C; Lin X; Clements BA; Rutkowski D; Ghahary A; Weinfeld M
    Biomacromolecules; 2007 Apr; 8(4):1059-63. PubMed ID: 17335285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomes.
    Managit C; Kawakami S; Yamashita F; Hashida M
    J Pharm Sci; 2005 Oct; 94(10):2266-75. PubMed ID: 16136555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system.
    Nishikawa M; Yamauchi M; Morimoto K; Ishida E; Takakura Y; Hashida M
    Gene Ther; 2000 Apr; 7(7):548-55. PubMed ID: 10819569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution and anti-HBV effects of antisense oligodeoxynucleotides conjugated to galactosylated poly-L-lysine.
    Zheng SJ; Zhong S; Zhang JJ; Chen F; Ren H; Deng CL
    World J Gastroenterol; 2003 Jun; 9(6):1251-5. PubMed ID: 12800234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactose-poly(ethylene glycol)-grafted poly-L-lysine as hepatoma cell-tapgeted gene carrier.
    Choi YH; Liu F; Park JS; Kim SW
    Bioconjug Chem; 1998; 9(6):708-18. PubMed ID: 9815164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fate of plasmid DNA after intravenous injection in mice: involvement of scavenger receptors in its hepatic uptake.
    Kawabata K; Takakura Y; Hashida M
    Pharm Res; 1995 Jun; 12(6):825-30. PubMed ID: 7667185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo gene delivery to the liver using novel galactosylated cationic liposomes.
    Kawakami S; Fumoto S; Nishikawa M; Yamashita F; Hashida M
    Pharm Res; 2000 Mar; 17(3):306-13. PubMed ID: 10801219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic glycopeptide-based delivery systems for systemic gene targeting to hepatocytes.
    Anwer K; Logan M; Tagliaferri F; Wadhwa M; Monera O; Tung CH; Chen W; Leonard P; French M; Proctor B; Wilson E; Singhal A; Rolland A
    Pharm Res; 2000 Apr; 17(4):451-9. PubMed ID: 10870990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.